The year in interventional cardiology.
Dixon
Simon R
SR
William Beaumont Hospital, Royal Oak, Michigan, USA. sdixon@beaumont.edu.
Grines
Cindy L
CL
O'Neill
William W
WW
D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D017023:Coronary Angiography; D003327:Coronary Disease / Q000188:drug therapy*; D054059:Coronary Occlusion / Q000188:drug therapy; D023903:Coronary Restenosis / Q000517:prevention & control; D054855:Drug-Eluting Stents / Q000009:adverse effects; D054092:Foramen Ovale, Patent / Q000628:therapy; D017052:Hospital Mortality; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000187:drug effects; D000068799:Prasugrel Hydrochloride; D058919:Purinergic P2 Receptor Antagonists; D015642:Radiology, Interventional; D013876:Thiophenes / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D058919:Purinergic P2 Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine